FDA-BACKED REFORM BILL TO PREEMPT REPUBLICAN PROPOSALS UNDER CONSIDERATION BY AGENCY; SEN. WYDEN TO INTRODUCE FDA REFORM, HUMAN TISSUE LEGISLATION
This article was originally published in The Gray Sheet
Executive Summary
FDA is considering floating its own legislative reform proposal during the 105th Congress as a preemptive measure against anticipated Republican bills on agency reform. Early introduction of an FDA-backed bill would give the GOP a benchmark for gauging what provisions the Clinton Administration is willing to support.